scieee Open visual document viewer

Ginsenosides act as positive modulators of P2X4 receptors

Dhuna, K.; Felgate, M.; Bidula, S.M.; Walpole, Samuel; Bibic, L.; Cromer, B.A.; Angulo Álvarez, Jesús; Sanderson, J.; Stebbing, M.J.; Stokes, L.

Abstract

We investigated the selectivity of protopanaxadiol ginsenosides from Panax ginseng acting as positive allosteric modulators on P2X receptors. ATP-induced responses were measured in stable cell lines overexpressing human P2X4 using a YOPRO-1 dye uptake assay, intracellular calcium measurements, and whole-cell patch-clamp recordings. Ginsenosides CK and Rd were demonstrated to enhance ATP responses at P2X4 by ∼twofold, similar to potentiation by the known positive modulator ivermectin. Investigations into the role of P2X4 in mediating a cytotoxic effect showed that only P2X7 expression in HEK-293 cells induces cell death in response to high concentrations of ATP, and that ginsenosides can enhance this process. Generation of a P2X7-deficient clone of BV-2 microglial cells using CRISPR/ Cas9 gene editing enabled an investigation of endogenous P2X4 in a microglial cell line. Compared with parental BV-2 cells, P2X7-deficient BV-2 cells showed minor potentiation of ATP responses by ginsenosides, and insensitivity to ATP 2 or ATP 1 ginsenoside-induced cell death, indicating a primary role for P2X7 receptors in both of these effects. Computational docking to a homology model of human P2X4, based on the open state of zfP2X4, yielded evidence of a putative ginsenoside binding site in P2X4 in the central vestibule region of the large ectodomain.

Full text

1521-0111/95/2/210–221$35.00 h ps://doi.o g/10.1124/mol.118.113696 MOLECULAR PHARMACOLOGY Mol Pha macol 95:210–221, Feb ua y 2019 Copy igh ª2019 The Au ho (s). This is an open access a icle dis ibu ed unde he CC BY A ibu ion 4.0 In e na ional license. Ginsenosides Ac As Posi i e Modula o s o P2X4 Recep o s s Kshi ija Dhuna, Ma hew Felga e, S e an M. Bidula, Samuel Walpole, Lucka Bibic, B e A. C ome , Jesus Angulo, Julie Sande son, Ma in J. S ebbing, and Leanne S okes School o Heal h and Biomedical Sciences, RMIT Uni e si y, Bundoo a, Vic o ia, Aus alia (K.D., B.A.C., M.J.S., L.S.); School o Pha macy, Uni e si y o Eas Anglia, No wich Resea ch Pa k, No wich, Uni ed Kingdom (M.F., S.M.B., S.W., L.B., J.A., J.S., L.S.); Depa men o Chemis y and Bio echnology, Swinbu ne Uni e si y o Technology, Haw ho n, Vic o ia, Aus alia (B.A.C.); and Flo ey Ins i u e o Neu oscience and Men al Heal h, Depa men o Ana omy and Neu oscience, Uni e si y o Melbou ne, Vic o ia, Aus alia (M.J.S.) Recei ed July 23, 2018; accep ed Decembe 10, 2018 ABSTRACT We in es iga ed he selec i i y o p o opanaxadiol ginsenosides om Panax ginseng ac ing as posi i e allos e ic modula o s on P2X ecep o s. ATP-induced esponses we e measu ed in s able cell lines o e exp essing human P2X4 using a YOPRO-1 dye up ake assay, in acellula calcium measu emen s, and whole- cell pa ch-clamp eco dings. Ginsenosides CK and Rd we e demons a ed o enhance ATP esponses a P2X4 by ∼ wo old, simila o po en ia ion by he known posi i e modula o i e mec- in. In es iga ions in o he ole o P2X4 in media ing a cy o oxic e ec showed ha only P2X7 exp ession in HEK-293 cells induces cell dea h in esponse o high concen a ions o ATP, and ha ginsenosides can enhance his p ocess. Gene a ion o a P2X7-de icien clone o BV-2 mic oglial cells using CRISPR/ Cas9 gene edi ing enabled an in es iga ion o endogenous P2X4 in a mic oglial cell line. Compa ed wi h pa en al BV-2 cells, P2X7- de icien BV-2 cells showed mino po en ia ion o ATP e- sponses by ginsenosides, and insensi i i y o ATP 2 o ATP 1 ginsenoside-induced cell dea h, indica ing a p ima y ole o P2X7 ecep o s in bo h o hese e ec s. Compu a ional docking o a homology model o human P2X4, based on he open s a e o z P2X4, yielded e idence o a pu a i e ginsenoside binding si e in P2X4 in he cen al es ibule egion o he la ge ec odomain. In oduc ion P2X ecep o s a e a amily o ATP-ga ed nonselec i e ca ion channels o which he e a e se en known subuni s (P2X1–7) wi h a ying exp ession pa e ns (No h, 2002). Thei physiological oles ange om he egula ion o mem- b ane po en ial and in acellula calcium concen a ion (all P2X ecep o s) o he egula ion o media o sec e ion such as in e leukin 1b(IL-1b) and b ain-de i ed neu o ophic ac o (BDNF) by P2X7 and P2X4, espec i ely. In es iga ions in o d ugs ha can modula e he ac i i y o P2X ecep o s ha e been qui e in ensi e in he las decade, wi h success ul iden i ica ion o selec i e an agonis s o many o he P2X amily, as e iewed in Ba le e al. (2014) and S okes e al. (2017). We ecen ly epo ed he iden i ica ion o a se ies o posi i e allos e ic modula o s o P2X7 ound in ex ac s o he adi ional Chinese medicinal plan , Panax ginseng (Helliwell e al., 2015). In his wo k, we ha e u he in es- iga ed he selec i i y o ginsenosides o P2X7 wi hin he P2X amily, ocusing on pu ine gic ecep o s ypically coex- p essed wi h P2X7 in immune cells, namely P2X4, P2Y1, and P2Y2 (Bowle e al., 2003). P2X4 is one o he mos ubiqui ously exp essed P2X ecep o s (So o e al., 1996) and has been implica ed in se e al physiological pa hways in di e en issues. P ominen ex- p ession o P2X4 has been demons a ed in endo helial cells, immune cells, and neu ons, as e iewed in S okes e al. (2017). An impo an ole o P2X4 in asodila ion esponses o shea s ess was elucida ed in 2000 (Yamamo o e al., 2000), and ansgenic mice lacking P2X4 la e con i med a ole in ni ic oxide p oduc ion and essel emodelling (Yamamo o e al., 2006). In he cen al ne ous sys em (CNS), P2X4 has been implica ed in long- e m po en ia ion (Sim e al., 2006) and in he pa hophysiology associa ed wi h neu opa hic pain (Tsuda e al., 2003; Coull e al., 2005). P2X4 exp essed on spinal co d mic oglia is in ol ed in ac i a ion o mic oglia and elease o media o s, including BDNF, which al e senso y neu onal pain ansmission pa hways (Coull e al., 2005; Ulmann e al., 2008). Da a sha ing Reques s o aw expe imen al da a om his s udy should be di ec ed o he co esponding au ho . This wo k was pa ly suppo ed by a s a egic g an om RMIT Uni e si y Heal h Inno a ions Resea ch Ins i u e, a RMIT Uni e si y Vice Chancello s Resea ch Fellowship, a Uni e si y o Eas Anglia School o Pha macy s a -up und, and a Bio echnology and Biological Sciences Resea ch Council p ojec g an awa ded o L.S. [BB/N018427/1]. K.D. was suppo ed by a RMIT Uni e si y PhD schola ship (2014–2018). J.A. and S.W. a e suppo ed by a Bio echnology and Biological Sciences Resea ch Council p ojec g an [BB/ P010660/1] and a Bio echnology and Biological Sciences Resea ch Council– unded NRPDTP s uden ship [1654460], espec i ely. h ps://doi.o g/10.1124/mol.118.113696. sThis a icle has supplemen al ma e ial a ailable a molpha m. aspe jou nals.o g. ABBREVIATIONS: ANOVA, analysis o a iance; BDNF, b ain-de i ed neu o ophic ac o ; BSA, bo ine se um albumin; CK, compound K; CNS, cen al ne ous sys em; DMEM, Dulbecco’s modi ied Eagle’s medium; DMSO, dime hylsul oxide; MTS, 3-(4,5-dime hyl hiazol-2-yl)-5-(3- ca boxyme hoxyphenyl)-2-(4-sul ophenyl)-2H- e azolium, inne sal ; PAM, posi i e allos e ic modula o ; PBS, phospha e-bu e ed saline; PPD, p o opanaxadiol; RMSD, oo -mean-squa e de ia ion; TBST, T is-bu e ed saline/Tween 20. 210 h p://molpha m.aspe jou nals.o g/con en /suppl/2018/12/13/mol.118.113696.DC1 Supplemen al ma e ial o his a icle can be ound a : a ASPET Jou nals on June 8, 2020molpha m.aspe jou nals.o gDownloaded om Also in he CNS, a ole o P2X4 has been desc ibed in alcohol-in ake beha io due o egula ion o he dopamine ewa d pa hway in he b ain (Asa yan e al., 2011; F anklin e al., 2015; Khoja e al., 2016). Finally, in he immune sys em, P2X4 plays a ole in he egula ion o CXCL5 p oduc ion and sec e ion om monocy es and mac ophages (Layhadi e al., 2018). Many o he oles o P2X4 ha e been elucida ed using ansgenic P2X4 2/2 mice o sho hai pin RNA knockdown o he ecep o because selec i e and po en an agonis s o P2X4 ha e only ecen ly been desc ibed. These include PSB-12062, BX430, NP-1815-PX, and 5-(3-B omophenyl)- 1,3-dihyd o-2H-benzo u o[3,2-e]-1,4-diazepin-2-one (5-BDBD) (He nandez-Olmos e al., 2012; Balázs e al., 2013; Ase e al., 2015; Ma sumu a e al., 2016; S okes e al., 2017). In con as o an agonis s, ela i ely ew posi i e allos e ic modula o s (PAMs) ha e been desc ibed o P2X ecep o s. Possibly he bes known PAM o P2X ecep o s is i e mec in, which has mos ac i i y a P2X4 (Khakh e al., 1999b; P iel and Silbe be g, 2004), al hough i also has some epo ed posi i e modula o ac i i y on human P2X7 (Nö enbe g e al., 2012). O he han i e mec in, cibac on blue, enidap, clemas ine, p oges e one, and e ahyd odeoxyco icos e one ha e been iden i ied as posi i e modula o s o P2X4, P2X7, and P2X2, espec i ely (Mille e al., 1998; Sanz e al., 1998; De Roo e al., 2010; Nö enbe g e al., 2011). In addi ion, ace me als such as zinc and coppe ha e PAM ac i i y a se e al P2X ecep- o s, including P2X2 and P2X4, as e iewed by Coddou e al. (2011a,b). Ginsenosides a e i e penoid saponins ound in he oo ex ac o plan s belonging o P. ginseng. Two subclasses o ginsenosides exis , designa ed p o opanaxadiols (PPD) and p o opanax iols (PPT) due o he posi ioning o glycoside a achmen s on he molecules. Ginsenosides ha e been e- po ed o ac on a numbe o ion channels such as ol age- ga ed Na 1 and K 1 channels, GABA A , and 5-HT 3 ecep o s (Nah, 2014). O he cons i uen s o ginseng such as he glycolipop o ein gin onin ha e been shown o po en ia e P2X1 ecep o s (Choi e al., 2013). In ou p e ious s udy (Helliwell e al., 2015), we demons a ed ha he majo ginsenoside me aboli e gene a ed in i o, compound K (CK), in addi ion o p o opanaxadiol ginsenosides Rd, Rb1, and Rh2, ac s on P2X7 o po en ia e he ac ion o ATP. Ginsenosides educed he EC 50 o he physiologic agonis , ATP, a mouse and human P2X7 and enhanced ATP-induced cell dea h in he J774 mouse mac ophage cell line (Helliwell e al., 2015). In his s udy, we demons a e ha he p o opanaxadiol ginseno- sides Rd and CK ha e a simila po en ia ing ac ion on P2X4, mos likely h ough a highly simila binding si e iden i ied in he cen al es ibule egion; howe e , he magni ude o he po en ia ing e ec on P2X4 is less han a P2X7. Ma e ials and Me hods Ma e ials. ATP (A7699; Sigma-Ald ich, S . Louis, MO) was p e- pa ed in dis illed wa e and adjus ed o pH 7.4 wi h 5 M NaOH. Aliquo s we e s o ed a 220°C and used only once. 5-(3-B omophenyl)- 1,3-dihyd o-2H-benzo u o[3,2-e]-1,4-diazepin-2-one (5-BDBD) (Toc is Biosciences, Bio-Techne L d., Abingdon, U.K.) was p epa ed in dime hylsul oxide (DMSO) a 10 mM and s o ed a 220°C. PSB- 12062 (SML0753; Sigma-Ald ich) was p epa ed in dis illed wa e o 10 mM. I e mec in (Toc is Biosciences) was p epa ed a 30 mM in DMSO and s o ed a 220°C. Ginsenosides CK, Rd, Rb1, Rh2, and p o opanaxadiol (PPD) (99% pu i y) we e pu chased om Shanghai Richem In e na ional L d., Shanghai, China, and 10 mM s ocks we e p epa ed in s e ile DMSO (Sigma-Ald ich) in glass ials. S ock solu ions we e s o ed a 220°C. The G115 s anda dized ginseng ex ac was a gi o P o esso C. C. Xue (RMIT Uni e si y, Aus alia) and was p epa ed in wa e , as desc ibed in Helliwell e al. (2015). Cell Cul u e. S ably ans ec ed HEK-293 cells we e main ained in Dulbecco’s modi ied Eagle’s medium (DMEM):F12 media con ain- ing L-glu amine (ca . no. 11320-034; Li e Technologies, Fishe Scien- i ic, Wal ham, MA) supplemen ed wi h 10% e al bo ine se um (US o igin, ca . no. F2442; Sigma-Ald ich) and 100 U/ml penicillin plus 100 mg/ml s ep omycin (Fishe Scien i ic, Wal ham, MA). S ably ans ec ed 1321N1 cells we e main ained in DMEM high-glucose media supplemen ed wi h 10% e al bo ine se um and 100 U/ml penicillin plus 100 mg/ml s ep omycin. To main ain s able exp ession o P2X cons uc s, 400–800 mg/ml gene icin (Gibco, Fishe Scien i ic) was added o he cul u e media. Ini ial ansien ans ec ions o HEK-293 cells we e pe o med in 35-mm pe i dishes using 0.1–1mg plasmid DNA (Glu-Glu- agged hP2X4 o hP2X7 in pcDNA3) and Lipo ec amine 2000 (3 ml/mg DNA) complexes in Op iMem media (Fishe Scien i ic). Cells we e pla ed in o 96-well pla es (ca . no. 167008; Nunc, Fishe Scien i ic, Wal ham, MA) p ecoa ed wi h 50 mg/ml poly-D-lysine (Me ck Millipo e, Bu ling on, MA), and pla es we e incuba ed o e nigh be o e expe imen s. Mouse mic oglial cell line BV-2 (a gi o D . B. Gu, Flo ey Ins i u e o Neu osciences, Melbou ne) was main ained in DMEM:F12 media con aining L-glu amine (ca . no. 11320-034; Li e Technologies) sup- plemen ed wi h 10% e al bo ine se um (Sigma-Ald ich US o igin, F2442) and 100 U/ml penicillin plus 100 mg/ml s ep omycin (Li e Technologies). CRISPR/Cas9 Gene Edi ing. Complemen a y RNA was designed agains exon 2 o mouse P2RX7, and wo RNA cons uc s we e pu chased om Dha macon (GE Heal hca e, Chicago, IL). BV-2 cells (120,000 cells/well) in a six-well pla e we e ans ec ed wi h endo oxin- ee 1 mg Edi R-Cas9 plasmid wi h blas icidin esis ance (GE Heal h- ca e Dha macon, La aye e, CO) plus 25 nM a ge RNA and 25 nM complemen a y RNA o P2RX7 using Dha ma ec DUO eagen (4 ml). Following 24-hou incuba ion, media we e eplaced, and, a e an addi ional 72-hou incuba ion, blas icidin was added o a inal concen- a ion o 1 mg/ml. An ibio ic selec ion was pe o med o 5 days, and emaining cells we e le o expand o analysis o gene edi ing. Cells we e es ed o lack o P2X7 exp ession using low cy ome y. Success ul wells showing lack o P2X7 exp ession unde wen single-cell cloning in 96-well pla es, and mul iple clones we e sc eened o lack o exp ession. Genomic DNA was ex ac ed om success ul clones and ampli ied by polyme ase chain eac ion o he P2RX7 exon 2 egion. Polyme ase chain eac ion p oduc s we e sen o sequencing o e i y mu a ions in his egion (Eu o ins Genomics, Ebe sbe g, Ge many). Flow Cy ome y and Immuno luo escence. BV-2 cells (5 10 5 cells) we e s ained wi h a an i-mouse P2X7 an ibody (Hano43; Enzo Li e Sciences UK L d, Exe e , U.K.) a 1:10 dilu ion in cold phospha e- bu e ed saline (PBS)/0.5% bo ine se um albumin (BSA) bu e . S ain- ing was pe o med on ice o 1 hou . Cells we e washed wi h PBS/0.5% BSA bu e and s ained wi h a goa an i- a IgG Alexa488 seconda y an ibody (Fishe Scien i ic) a 1:200 dilu ion o 1 hou on ice. Following washing wi h PBS/0.5% BSA bu e , cells we e esuspended in 300 ml PBS/0.5% BSAbu e o acquisi ion on a FACSCalibu o on a Cy o lex low cy ome e . Fo immuno luo escence, cells we e g own o e nigh on 13-mm glass co e slips and washed wi h PBS p io o ixa ion wi h 4% pa a o maldehyde (Sigma-Ald ich). Cells we e pe meabilized using PBS/0.5% BSA bu e con aining 0.1% saponin (Sigma-Ald ich) and blocked o 1 hou . Rabbi an i-P2X4 (Alomone Labo a o ies, Je usalem, Is ael) was used a 1:200 dilu ion in PBS/0.5% BSA bu e , and cells we e s ained o e nigh . Following washing, an i- abbi IgG Alexa 568 was used a 1:200 dilu ion in PBS/0.5% BSA bu e . Co e slips we e moun ed on o glass slides using P olong Gold an i ade con aining Posi i e Modula ion o P2X4 211 a ASPET Jou nals on June 8, 2020molpha m.aspe jou nals.o gDownloaded om 49,69-diamidino-2-phenylindole (Fishe Scien i ic). A Zeiss AxioPlan 2ie up igh luo escen mic oscope was used o ake he images. Wes e n Blo ing. Whole-cell lysa es we e p epa ed in adio- immunop ecipi a ion assay lysis bu e (Fishe Scien i ic) con aining p o ease inhibi o s (Fishe Scien i ic). Cell pelle s we e dis up ed wi h a pipe e ip and lysed on ice o 30 minu es. Lysa es we e hen clea ed by cen i uga ion a 10,000g o 10 minu es, and supe na- an s we e ans e ed in o clean ubes. P o ein was measu ed using a bicinchoninic acid assay (Pie ce, Fishe Scien i ic, Wal ham, MA) wi h BSA as s anda d (2 mg/ml o 20 ng/ml). Abso bance a 562 nm was measu ed using a Flexs a ion 3 pla e eade (Molecula De ices, San Jose, CA). A quan i y amoun ing o 25 mg o al p o ein was loaded pe lane on o a Bol 4%–12% Bis–T is gel (Fishe Scien i ic) using he supplied gel-loading bu e plus educing agen . Elec opho esis was pe o med using 1MES bu e . P o ein was ans e ed on o poly inylidene di luo ide memb ane (Immo- bilon P; Fishe Scien i ic) using semid y ans e o 60 minu es. Memb anes we e blocked wi h 5% non a milk solu ion in T is- bu e ed saline/Tween 20 (TBST) o e nigh a 4°C. P ima y an i- bodies we e incuba ed o 2 hou s a oom empe a u e in 5% non a milk solu ion in TBST. An i-P2X4 (APR-004; Alomone Labo a o- ies) and an i-P2X7 C- e minal an ibody (APR-002; Alomone Lab- o a o ies) we e bo h used a 1:2000 dilu ion. A goa an i- abbi IgG-ho se adish pe oxidase seconda y (Sigma-Ald ich) was used a 1:2000 dilu ion. Blo s we e s ipped, washed, eblocked, and hen ep obed o b-ac in using a mouse monoclonal an i–b-ac in an i- body (A5316; Sigma-Ald ich) a 1:2000 dilu ion in 5% non a milk solu ion in TBST. An an i-mouse IgG-ho se adish pe oxidase (Sigma-Ald ich) seconda y was used a 1:10,000 dilu ion. Lumina a chemiluminescen subs a e (Me ck Millipo e) was used o de- elop blo s, and images we e aken using an Image Quan LAS 4000 image . Dye Up ake Expe imen s. Fo YOPRO-1 dye up ake expe i- men s, cells we e pla ed a a densi y o 2 10 4 cells/well in comple e DMEM:F12 media (100 ml pe well) in poly-D-lysine–coa ed 96-well pla es. Media we e emo ed using a manual mul ichannel pipe e and eplaced wi h a low di alen ca ion bu e (145 mM NaCl, 2 mM KCl, 13 mM D-glucose, 10 mM HEPES, and 0.1 mM CaCl 2 , pH 7.3) con aining 2 mM YO-PRO-1 iodide (ca . no. Y3663; Li e Technologies). Fo p eincuba ion expe imen s, he cells we e ea ed wi h ginseno- sides (10 mM) in YO-PRO–con aining low di alen ca ion bu e . Fo he majo i y o expe imen s, ginsenosides we e coinjec ed simul a- neously wi h he agonis using a Flexs a ion 3 mic opla e eade (Molecula De ices). Ginsenosides and agonis we e p epa ed a 10 inal concen a ion in he compound pla e. Dye up ake o e ime was eco ded using an exci a ion wa eleng h o 488 nm and an emission wa eleng h o 520 nm on he Flexs a ion 3 (six eads/well, pho o- mul iplie ube (PMT) se ing medium). Basal luo escence measu e- men s we e acqui ed o 40 seconds, ollowed by au oma ic injec ion o agonis , and he kine ic measu emen o luo escence in ensi y was pe o med o 300 seconds using So max P o 5.4 so wa e. Dye up ake esponses we e calcula ed as a ea unde he cu e om 50 o 300 seconds using ze o baseline no malized da a. In acellula Calcium Measu emen s. HEK-293, HEK-hP2X4 cells, and 1321N1-hP2X4 cells in poly-D-lysine–coa ed 96-well pla es we e loaded wi h 2 mM Fu a-2 ace oxyme hyl es e (Fishe Scien i ic o HelloBio, B is ol, U.K.) in Hanks’balanced sal solu ion bu e con aining 250 mM sul inpy azone (Sigma-Ald ich) o 40–60 minu es Fig. 1. P o opanaxadiol ginsenosides and G115 inc ease hP2X4-media ed YOPRO-1 up ake esponses. (A) Rep esen a i e da a showing YOPRO-1 up ake in esponse o ATP (5 mM) in he p esence o i e mec in (IVM, 3 mM) o 5-BDBD (20 mM). (B) Summa y a ea unde cu e da a om no malized YOPRO-1 up ake in HEK-hP2X4 cells (n= 3 independen expe imen s). E o ba s ep esen S.D.; * ep esen s P,0.05 by one-way ANOVA wi h Dunne ’s mul iple compa ison pos hoc es . (C) YOPRO-1 up ake esponses in HEK-hP2X4 cells o ATP (5 mM) in low di alen bu e solu ion (black) o ATP plus PPD (pu ple; 10 mM) and ATP plus CK ( ed; 10 mM). Ginsenosides we e coinjec ed wi h he agonis ATP. (D) Da a ha e been quan i ied as a ea unde dye up ake cu e (50–180 seconds). Ba g aphs show da a om h ee o i e independen expe imen s. E o ba s ep esen S.D.; * ep esen s P,0.05 by one-way ANOVA wi h Dunne ’s mul iple compa ison pos hoc es , ns ep esen s no signi ican . 212 Dhuna e al. a ASPET Jou nals on June 8, 2020molpha m.aspe jou nals.o gDownloaded om a 37°C. Following loading, bu e was emo ed using a mul ichannel pipe e and eplaced wi h s anda d ex acellula bu e o low di alen bu e . Cells we e wa med o 10 minu es be o e measu emen s we e s a ed. Fu a-2 was measu ed a exci a ion wa eleng hs 340 and 380 nm wi h emission wa eleng h 520 nm using a Flexs a ion 3 pla e eade . Sampling in e al was 3.5 seconds and h ee eads/well. Fu a-2 a io was calcula ed using So max P o 5.4, and esponses we e measu ed using a ea unde cu e kine ic educ ion. Calcium esponses in pa en al and P2X7-de icien BV-2 cells we e pe o med using a Fu a-2-QBT ki (Molecula De ices). Reagen was p epa ed in low di alen bu e con aining 250 mM sul inpy azone and added o cells pla ed in o poly-D-lysine–coa ed 96-well pla es o 60 minu es (180 ml/well). Using he Fu a-2-QBT ki elimina ed he washing s ep om he p ocedu e, ensu ing ha no cells we e los om he pla e. Fu a-2 luo escence was measu ed a exci a ion wa e- leng hs 340 and 380 nm wi h emission wa eleng h 520 nm using a Flexs a ion 3 pla e eade . Sampling in e al was 3.5 seconds and h ee eads/well. Fu a-2 a io was calcula ed using So max P o 5.4, and esponses we e measu ed using a ea unde cu e kine ic e- duc ion. Condi ions we e applied in iplica e, and expe imen s we e pe o med ou independen imes. Cell Viabili y. Viabili y expe imen s we e pe o med using he CellTi e 96 Aqueous Non-Radioac i e Cell P oli e a ion assay (G3580, P omega, Madison, WI), a colo ime ic me hod o de e mining he numbe o iable cells. HEK-293 cells we e pla ed a 5 10 4 cells/well in comple e DMEM:F12 media and le o 24 hou s unde no - mal g ow h condi ions. T ea men s we e hen added o he cells (2 inal concen a ion) and incuba ed o an addi ional 24 hou s. 3-(4,5-dime hyl hiazol-2-yl)-5-(3-ca boxyme hoxyphenyl)-2-(4-sul o- phenyl)-2H- e azolium, inne sal (MTS) solu ion (20 ml) was added o media in each well 1–4 hou s be o e he s ipula ed end poin ime. Abso bance was measu ed a 490 nm using a Cla ios a pla e eade (BMG Lab ech L d., Aylesbu y, U.K.) o a Flexs a ion 3 pla e eade . Pa ch Clamping. HEK-293 cells s ably exp essing hP2X4 we e pla ed on o 13-mm glass co e slips 24 hou s be o e eco ding ATP- induced memb ane cu en s in he whole-cell pa ch clamp con igu a- ion. An EPC10 ampli ie (HEKA Elek onik, Ha a d Bioscience Inc., Lamb ech /P alz, Ge many) was used o ol age clamp cells a 260 mV. Bo osilica e glass elec odes (Wo ld P ecision Ins u- men s, Hi chin, U.K.) had a esis ance o 5–8MVwhen illed wi h s anda d in e nal solu ion (145 mM NaCl, 10 mM HEPES, 10 mM EGTA, pH 7.3, wi h 5 M NaOH). Cells we e con inually pe used by a g a i y eed wi h s anda d ex acellula bu e solu ion (145 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 13 mM glucose, 10 mM HEPES, pH 7.3) p io o seal o ma ion. ATP and ginsenosides we e applied using a compu e -con olled as - low sys em (Bio-Logic Science Ins umen s, Seyssine -Pa ise , F ance) wi h he pe usion capilla ies placed in close p oximi y o he cell unde in es iga ion. Cells we e dialyzed wi h in e nal solu ion o 1 minu e, and ATP in he absence o p esence o ginsenoside was applied e e y minu e o ou applica ions. Molecula Modeling and Docking. The coo dina es o zeb a ish P2X4 in he ATP-bound open s a e (Ha o i and Gouaux, 2012) (P o ein Da a Bank: 4DW1) we e used as a empla e. The sequence o human P2X4 was aligned o he empla e using he Clus alW algo i hm (La kin e al., 2007). The Sch ödinge P ime so wa e (www.sch odinge .com) was used o cons uc an ene gy-based all- a om model wi h he OPLS3 o ce ield keeping he ATP coo dina es om he empla e. Th ee-dimensional models o he ginsenosides CK and Rd we e gene a ed using LigP ep so wa e wi hin he Sch ö- dinge Maes o sui e (www.sch odinge .com). The OPLS3 o ce ield was used o gene a e 32 low-ene gy con o me s o each ginsenoside. Induced i docking was pe o med using he au oma ed ex ended sampling p o ocol in he Sch ödinge Maes o sui e (She man e al., 2006). This i s pe o ms se e al ini ial docking uns in which side chains a e ei he immed, o hei Van de Waals po en ials so ened acco ding o hei lexibili y. Side chains a e hen ebuil , and hose wi hin 5 Å o he ligand a e op imized using P ime. Ligands we e hen edocked o he new ecep o s uc u e using he Glide SP algo i hm (F iesne e al., 2004) and s anda d po en ials. S uc u es wi hin 30 kcal mol 21 o he lowes ene gy s uc u e we e e ained. The ecep o g id was cen e ed on he highes -sco ing po en ial binding si e, ound using Si emap (Halg en, 2007), and had cubic box dimensions o 30 Å. Each o he 32 con o me s was docked using he ex ended sampling p o ocol. Fo each ginsenoside, he esul ing poses we e clus e ed by hea y a om oo -mean-squa e de ia ion (RMSD) using he a e age-linkage me hod, and a ep esen a i e s uc u e was chosen om he model closes o he cen oid o he mos popula ed clus e . Fo CK and Rd, he mos popula ed clus e made up 46% and 82% o all solu ions, espec i ely. S a is ical Analysis. G aphs we e plo ed using G aphPad P ism e sions 6 o 7 (La Jolla, CA). Concen a ion– esponse cu es we e i ed using a log (agonis ) e sus esponse– a iable slope ( ou pa ame e ) bes - i equa ion. Da a we e analyzed o s a is ical signi - icance using one-way analysis o a iance (ANOVA) o wo-way ANOVA wi h pos hoc es s as app op ia e (G aphPad P ism). Signi icance was aken as P,0.05. Resul s Fo ou in es iga ion in o he selec i i y o p o opanaxadiol ginsenosides o P2X7, we chose he closely ela ed P2X4 ecep o because his is known o be coexp essed wi h P2X7 in mac ophages and o he immune cells. We i s gene a ed a HEK-293 cell line s ably exp essing a Glu-Glu C- e minal Fig. 2. Ginsenosides enhance ATP esponses a ecombinan hP2X4. (A) Va ious concen a ions o ATP (100 nM o 100 mM) we e used o ac i a e hP2X4, and YOPRO-1 up ake o e 200 seconds was measu ed on a Flexs a ion 3. Concen a ion esponse o ATP is shown in black, ATP in he p esence o 10 mM CK is shown in ed, and ATP in he p esence o i e mec in (IVM; 5 mM) is shown in o ange. Da a a e aken om h ee independen expe imen s, and e o ba s ep esen S.E.M. T ans o med da a we e cu e i using nonlinea eg ession, and EC 50 alues we e 1.92 mM ATP, 1.22 mM o ATP + CK, and 1.3 mM o ATP + IVM. (B) Concen a ion esponse ela ionship o selec ginsenosides on YOPRO-1 dye up ake o 5 mM ATP in HEK-hP2X4 cells. Ginsenosides we e es ed o e he ange 0.1–50 mM. EC 50 alues we e 7.5 mM Rd, 8.5 mM CK, and 10.5 mM Rb1. Da a we e aken om h ee independen expe imen s. Posi i e Modula ion o P2X4 213 a ASPET Jou nals on June 8, 2020molpha m.aspe jou nals.o gDownloaded om agged human P2X4 (HEK-hP2X4) and es ablished an assay o measu e P2X4-media ed seconda y po e esponses ia YOPRO-1 dye up ake using a Flexs a ion 3 pla e eade . The ATP-induced YOPRO-1 dye up ake esponse could be inc eased by i e mec in (3–5mM) and educed by he known P2X4 an agonis 5-BDBD (20 mM) (Fig. 1). This con i ms ha P2X4 ecep o s can elici a la ge po e esponse in HEK-293 cells (Be nie e al., 2012). The s anda dized ginseng ex ac G115 (100 mg/ml) was also ound o inc ease he P2X4 dye up ake esponse (Fig. 1B). We in es iga ed he e ec o he indi idual pu i ied ginsenoside chemicals on P2X4-media ed YOPRO-1 dye up ake esponses in HEK-293 cells. To do his, we coinjec ed 10 mM o he ollowing ginsenosides—CK, Rd, Rb1, Rh2, o he aglycone PPD— oge he wi h ATP. Simila o he epo ed po en ia ion o P2X7 (Helliwell e al., 2015), he ginsenosides also po en ia ed P2X4 esponses (Fig. 1, C and D). The da a sugges ha Rd, CK, and Rb1 can po en ia e P2X4 (P,0.05), whe eas Rh2 and PPD had no e ec on ATP-induced P2X4 po e esponses in HEK-293 cells. We in es iga ed whe he ginsenoside CK could shi he concen a ion– esponse cu e o ATP and al e he sensi i i y o he P2X4 ecep o o he agonis . We p e iously epo ed ha ginsenosideCK educed heEC 50 o ATPa P2X7 in addi ion o inc easing he maximum esponse elici ed by ATP (Helliwell e al., 2015). Using heYOPRO-1 up ake assay, 10 mMCKcould inc ease he maximum esponse induced by ATP, simila o he e ec o he posi i e modula o i e mec in (5 mM) (Fig. 2A). The EC 50 alue o ATP was 1.92 mM (95% con idence in e al 1.03 o 3.56 mM) compa ed wi h 1.22 mM (con idence in e al 0.49 o 2.99 mM) in he p esence o CK, sugges ing ha CK does no d ama ically a ec sensi i i y o agonis . We also de e mined he EC 50 alue o each ginsenoside on po en ia ion o hP2X4 esponses (Fig. 2B), which we e Rd 7.5 mM (con idence in e al 5.74–9.91 mM), CK 8.5 mM (con idence in e al 5.88–12.4 mM), and Rb1 10.5 mM (con idence in e al 8.46–13.23 mM). Ou nex s ep was o in es iga e he e ec s o ginsenosides on P2X4-media ed calcium esponses using he HEK-hP2X4 s able cell line, as his is mo e physiologically ele an . Fu a-2 ace oxyme hyl es e –loaded HEK-hP2X4 cells we e chal- lenged wi h ATP (1 mM) in he absence o p esence o 10 mM CK, and calcium esponses we e measu ed o 300 seconds (Fig. 3A). Endogenous P2Y ecep o s a e known o con ibu e o he ATP-induced calcium esponses in HEK-293 cells; howe e , a sepa a e se o expe imen s con i med ha he ginsenosides did no po en ia e ADP- o UTP-media ed calcium esponses (Supplemen al Fig. 1). Bo h CK and Rd Fig. 3. Ginsenosides enhance Ca 2+ in lux esponses in cells exp essing hP2X4. In acellula Ca 2+ esponses we e measu ed in (A) Fu a-2 ace oxyme hyl es e –loaded HEK-hP2X4 cells o (C) Fu a-2 ace oxyme hyl es e –loaded 1321N1-hP2X4 cells. Baseline alues we e eco ded o 15–20 seconds, and hen ATP was au oma ically injec ed a 30 seconds (a ow indica es agonis addi ion). Rep esen a i e ATP esponses a e shown in black; ATP plus CK (10 mM) a e shown in ed. E o ba s a e S.D. (B) Ca 2+ esponses in HEK-hP2X4 we e calcula ed as a e age Fu a-2 a io o e he inal 150 seconds. CK and Rd (10 mM) signi ican ly inc ease hP2X4-media ed Ca 2+ in lux. *P,0.05, one-way ANOVA wi h Dunne ’s mul iple compa ison pos hoc es . (D) Ca 2+ esponses in 1321N1-hP2X4 cells we e measu ed as a ea unde he cu e o ze o baseline; e o ba s a e S.D.; da a a e om ou independen expe imen s. 214 Dhuna e al. a ASPET Jou nals on June 8, 2020molpha m.aspe jou nals.o gDownloaded om caused an inc ease in he sus ained calcium esponse media ed by hP2X4 in HEK-293 cells (Fig. 3B) (P,0.05). We also gene a ed a s able 1321N1 as ocy oma cell line exp essing hP2X4 and con i med ha he ginsenosides CK and Rd po en ia ed ATP-induced calcium esponses in his second cell ype (Fig. 3, C and D). Finally, o con i m ginsenoside po en ia ion o hP2X4 channel esponses, we used whole-cell pa ch clamp eco dings in HEK-hP2X4 cells. As o he s ha e shown, mul iple addi ions o ATP wi h a washou pe iod in be ween cause a undown e ec on esponses (Fig. 4A), in which he second esponse was 73% 65.8% o he ini ial esponse (n57 cells). Figu e 4B demons a es he e ec o coadminis e ing ATP in he p es- ence o CK o Rd as he second applica ion, showing ha he ginsenosides inc ease he ATP esponses. Figu e 4C sum- ma izes he pa ch clamp da a as no malized da a (pe cen - age o second ATP applica ion) (n57–10 cells). By measu ing indi idual P2X ecep o s he e ologously exp essed in HEK-293 and 1321N1 cells using a a ie y o expe imen al echniques, we ha e demons a ed ha se- lec ed ginsenosides, namely CK and Rd, can po en ia e P2X4 esponses. In ou p e ious s udy, we in es iga ed he downs eam consequences o po en ia ing P2X7 ecep o s wi h he ginsenoside CK by de e mining i s e ec on ATP- induced cell dea h in mac ophages (Helliwell e al., 2015). The e o e, we in es iga ed whe he P2X4 ecep o s play any ole in he induc ion o cell dea h and whe he ginsenosides could enhance his. We pe o med cell iabili y expe imen s using cell iabili y MTS abso bance assays in HEK-293 cells s ably exp essing ei he hP2X4 o hP2X7. In HEK-hP2X7 he e was a educ ion in cell iabili y wi h inc easing concen- a ions o ATP wi h concen a ions g ea e han 1 mM causing cell dea h (Fig. 5). The selec i e P2X7 an agonis AZ10606120 (10 mM) could e ec i ely block he cell dea h induced by hese high concen a ions o ATP (Fig. 5). The p esence o CK enhanced he le hal e ec o 500 mM ATP on P2X7 in hese expe imen s (Fig. 5). Con e sely, in HEK-hP2X4 cells, he e was no meaning ul educ ion in cell iabili y wi h inc easing concen a ions o ATP (Fig. 5); cells ea ed wi h 3 mM ATP we e ully iable (104% o con ol). Viabili ywas educed o 86% o con ol when 5-BDBD was in oduced in combina ion wi h high concen a ions o ATP (1 and 3 mM) and iabili y was educed o 76% o con ol when CK was in oduced wi h 3 mM ATP (Fig. 5, P,0.05). To in es iga e he con ibu ion o ginsenoside po en ia ion o P2X4 esponses e sus ginsenoside po en ia ion o P2X7 esponses in immune cells, we used he mouse mic oglia BV-2 cell line. These cells a e known o exp ess bo h P2X4 and P2X7 ecep o s (Gilbe e al., 2016; Asa yan e al., 2018). We gene a ed a P2X7-de icien BV-2 cell line using CRISPR/Cas9 gene-edi ing echnology di ec ed agains exon 2 o mouse P2X7. Single-cell clones o P2X7-de icien BV-2 cells we e gene a ed and cha ac e ized using low cy ome y and Wes - e n blo ing o de ec su ace and o al P2X7 p o ein, e- spec i ely (Fig. 6, A and B). P2X4 p o ein exp ession was no a ec ed in BV-2 cells lacking P2X7 (Fig. 6B), and he dis ibu ion o P2X4 appea ed simila in BV-2 and P2X7- de icien BV-2 cells (Fig. 6C). ATP (25 mM)-induced calcium esponses we e simila in he BV-2 and P2X7-de icien BV-2 cells and displayedP2X4-like pha macological p ope ies such as po en ia ion by i e mec in and educ ion in esponses by wo P2X4 an agonis s 5-BDBD and PSB-12062 (Fig. 6D, P,0.05). In he pa en al BV-2 cells, bo h ginsenosides CK and Rd ga e a s a is ically signi ican po en ia ion o he ATP-induced calcium esponse by 5.6- old and 6.05 old, espec i ely (Fig. 7A, P,0.05 by wo-way ANOVA); howe e , his e ec was d ama ically educed in cells lacking P2X7 ecep o s o 1.6- old (CK) and 1.1- old (Rd) po en ia ion (Fig. 7, A and B). This sugges s ha he majo i y o he ginsenoside e ec is due o hei ac ion on P2X7. We also demons a e ha Fig. 4. Pa ch clamp analysis con i ms CK, and Rd en- hances ATP-induced cu en s. HEK-hP2X4 cells we e ol - age clamped a 260 mV, and (A) ATP (5 mM) was apidly applied o 5 seconds (pulse deno ed by black ba s), ollowed by a 45-second washou wi h s anda d ex acellula solu- ion. In con ol cells, u he applica ions o ATP we e applied e e y 1 minu e o a o al o ou applica ions. Human P2X4 esponses we e obse ed o display consis en undown. (B) In ginsenoside- ea ed cells, an ini ial con ol applica ion o ATP was adminis e ed and hen he second applica ion was ATP plus CK o ATP plus Rd (bo h a 10 mM). (C) No malized cu en ampli udes (pA/pF) show- ing ATP undown o e he i s ou applica ions. Po en i- a ion o ATP esponses by CK ( ed) and Rd (blue) exp essed as pe cen age o second ATP esponse. Posi i e Modula ion o P2X4 215 a ASPET Jou nals on June 8, 2020molpha m.aspe jou nals.o gDownloaded om pa en al BV-2 cells we e success ully killed by 3 mM ATP, whe eas P2X7-de icien BV-2 cells we e p o ec ed om ATP- induced cell dea h (Fig. 7C). The addi ion o CK (10 mM) oge he wi h ATP did no induce o enhance any cell dea h in P2X7-de icien BV-2 cells (Fig. 7C). We ha e in es iga ed pu a i e binding si es on P2X4 and P2X7 ecep o s o he ginsenosides using a homology model o hP2X4 gene a ed om he c ys al s uc u e o z P2X4 in he ATP-bound open s a e (P o ein Da a Bank: 4DW1). The docking poses o bo h CK (Supplemen al Ma e ial 1) and Rd (Supplemen al Ma e ial 2) on hP2X4 we e simila o hose obse ed o hP2X7 (Fig. 8). The e a e no able di e ences in he leng h o he in e nal loop a he op bounda y o he cen al es ibule, wi h his sec ion being longe in hP2X4 and con aining wo nega i ely cha ged glu amic acid esidues (-QEENS-) in compa ison wi h neu al sequence -QGNS- in hP2X7. This addi ional s e ic epulsion o he longe in e - nal loop in P2X4, as well as elec os a ic epulsion o he diglu ama e mo i , may al e he binding mode o he ginseno- sides compa ed wi h hP2X7. Figu e 8, B and E, shows o e lays o he p edic ed docking poses o CK and Rd on hP2X7 and hP2X4. Se e al in e ac ing esidues ha e been highligh ed, including E96 in he in e nal loop, S62 and D58 in he b-2 shee , plus D320 in he b-14 shee . Ginsenoside Rd binds in an in e ed o ien a ion wi h espec o CK, which is simila o he docking pose obse ed on hP2X7 (unpublished da a). Discussion In his s udy, we ha e desc ibed a no el posi i e allos e ic modula o o P2X4 and highligh ed a pu a i e binding si e o posi i e allos e ic modula o s ha may be conse ed be ween P2X4 and P2X7 ecep o s. We ha e p esen ed pha macolog- ical da a o posi i e modula o ac i i y a P2X4 and ha e desc ibed impo an di e ences be ween ginsenoside ac ion a P2X4 and P2X7. To measu e P2X4 esponses, we used a YOPRO-1 dye up ake assay, which is mos commonly used o measu e P2X7 esponses. Ea lie wo ks sugges ed ha dye up ake esponses could also be induced by o he pu ine gic P2X ecep o s, including P2X4 (Khakh e al., 1999a; Vi ginio e al., 1999), and his was con i med by Be nie e al. (2012) in bo h ans ec ed HEK-293 cells and mic oglia. This migh sugges ha dye up ake is an in insic ea u e o P2X ecep o channels. Rega dless o he mechanism unde lying pe mea ion o la ge dye molecules, his is a po en ially use ul way o measu ing P2X4 esponses in a medium- o high- h oughpu sys em. We show ha dye up ake was induced by low concen a ions o ATP, was po en ia ed by i e mec in, and was educed by p e ea men o he cells wi h 5-BDBD, all cha ac e is ics o a P2X4-media ed e- sponse. In hese expe imen s, CK appea ed o be mo e e ec i e a enhancing ATP-induced esponses han i e - mec in (Figs. 1 and 2). Tes ing he p o opanaxadiol ginsenosides on P2X4 in YOPRO-1, calcium measu emen s and pa ch clamp eco dings e ealed some di e ences o P2X7; he mos s iking di e ence was ha Rd was equi alen o CK in he le el o po en ia ion i induced on P2X4, whe eas CK is mo e e ec i e a P2X7. O e all, he magni ude o po en ia ion obse ed o P2X4 was much lowe han on P2X7; ginsenosides ypically inc eased P2X4 esponses by ∼ wo old, whe eas his eached .20- old in P2X7 esponses by pa ch clamp analysis (Helliwell e al., 2015). The simila PAM ac ion on P2X4 and P2X7 p omp ed an in es iga ion in o whe he he p edic ed binding si e o ginsenosides would be he same. The e is a high deg ee o simila i y be ween hese channels, and we used he z P2X4 c ys al s uc u e o p edic he ATP-bound open s a es o hP2X4 and hP2X7. Di e ences in he binding poses we e obse ed and in amino acid esidues p edic ed o in e ac wi h bound ginsenosides, he oles o which will be in es iga ed in a mo e de ailed s udy. I is no able ha he p edic ed ginsenoside si e does no o e lap wi h he i e mec in binding si e on P2X4, which is hough o be loca ed wi hin he ansmemb ane domains (Jelínko á e al., 2006; Silbe be g e al., 2007; Popo a e al., 2013), sugges ing ha wo dis inc posi i e modula o binding si es exis o P2X4. In his s udy, we ha e paid pa icula a en ion o he cy o oxic ac ion o ATP. I is well known ha sus ained ac i a ion o P2X7 leads o cell dea h (O ioli e al., 2017), and we ha e shown ha ginsenosides can enhance his (Helliwell e al., 2015). The ole o o he pu ine gic ecep o s in cell dea h is no so clea , and he e o e we in es iga ed he in ol emen o P2X4 in his p ocess. We ound ha sus ained ac i a ion o hP2X4 o e exp essed in HEK-293 cells did no cause cell dea h (Fig. 5), and u he mo e, high concen a ions o ATP we e no cy o oxic in P2X7-de icicen BV-2 mic oglial Fig. 5. Ginsenoside CK does no enhance cell dea h in HEK-hP2X4 cells. HEK-293 cells s ably exp essing hP2X4 o hP2X7 (50,000 cells/well) we e pla ed in o 96-well pla es o 24 hou s p io o s imula ion wi h ATP. Cells we e p e ea ed wi h an agonis s AZ10606120 (AZ) o 5-BDBD o 10 minu es be o e ATP was added. Cells we e exposed o he indica ed concen a ions o ATP o ATP + CK (10 mM) o 24 hou s, and iabili y was measu ed using MTS abso bance. MTS was added o he inal 4 hou s o incuba ion, and abso bance ead using a Flexs a ion 3 eade . Da a we e no malized o cells ea ed wi h ehicle con ol and a e exp essed as pe cen age o con ol. Da a a e om ou independen expe imen s. 216 Dhuna e al. a ASPET Jou nals on June 8, 2020molpha m.aspe jou nals.o gDownloaded om Fig. 6. P2X4 esponses in gene-edi ed BV-2 cells o elimina e P2X7 ecep o s. BV-2 cells de icien o P2X7 we e gene a ed using CRISPR/Cas9 edi ing. (A) Flow cy ome y da a indica ing pa en al BV-2 cells exp ess P2X7 (black his og am), whe eas P2X7-de icien BV-2 cells show no P2X7-posi i e s ain (g een his og am) using Hano43 an ibody labeling. Red his og am indica es nega i e con ol, cells labeled wi h seconda y an ibody only. (B) Wes e n blo s showing no an i-P2X7 eac i e p o ein band in P2X7-de icien BV-2 cells compa ed wi h pa en al BV-2 and J774 mac ophages. Equal amoun s o p o ein (25 mg) we e loaded pe lane as indica ed by he b-ac in loading con ol on s ipped and ep obed blo s. P2X4 p o ein le els we e unchanged ollowing knockou o P2X7. (C) S aining o P2X4 ecep o s was pe o med using a ix/pe m me hod wi h cells g own on 13-mm glass co e slips. Rabbi an i-P2X4 (1:200) was used o label all P2X4 ecep o s in BV-2 pa en al and P2X7-de icien BV-2 cells. Images a e ep esen a i e o wo independen expe imen s. (D) In acellula calcium measu emen s in Fu a-2 ace oxyme hyl es e –loaded BV-2 and P2X7-de icien BV-2 show iden ical ATP (25 mM) esponses. ATP + i e mec in (3 mM) esponses we e educed by p e ea men o cells wi h 5-BDBD (10 mM) o PSB-12062 (1 mM). E o ba s a e S.D. and *P,0.05, one-way ANOVA wi h Dunne ’s mul iple compa ison pos hoc es . Posi i e Modula ion o P2X4 217 a ASPET Jou nals on June 8, 2020molpha m.aspe jou nals.o gDownloaded om cells (Fig. 7), sugges ing ha ac i a ion o P2X4 does no cause cell dea h. In HEK-hP2X7 cells, CK was able o enhance cell dea h o nonle hal concen a ions o ATP (500 mM), simila o J774 cells (Helliwell e al., 2015). This is likely due o he inc eased ecep o sensi i i y o ATP in he p esence o CK, allowing cells o o e come a h eshold le el o signaling o he ini ia ion o apop osis. CK was no as e ec i e a enhancing cell dea h in esponse o 1 o 3 mM ATP; howe e , his may be due o maximum cell dea h being induced by ull ac i a ion o P2X7. Posi i e allos e ic modula o s o P2X4 a e hough o be use ul in ea men o alcohol-use diso de s due o a compe - i i e e ec on channel ac i i y (Asa yan e al., 2010; Ya dley e al., 2012). E hanol has an inhibi o y e ec on P2X4 esponses and p e en s he ac ion o ATP, which in u n a ec s he modula ion o neu o ansmission in a ious e- gions o he b ain (F anklin e al., 2014). The binding o i e mec in o P2X4 is pos ula ed o coun e ac he binding o e hanol, hus p e en ing i s inhibi o y e ec on channel ac i a ion. I would be in e es ing o de e mine whe he posi i e allos e ic modula o s ha bind o o he egions o he channel will ha e a simila e ec on elimina ion o e hanol e ec s on P2X4. In addi ion o alcohol-use diso de s, P2X4 has been implica ed in he egula ion o dopamine-dependen beha io s (Khoja e al., 2016), sugges ing ha modula ion o P2X4 in he CNS may also be bene icial in dopamine - gic diso de s such as Pa kinson’s disease. In e es ingly, P. ginseng ex ac is epo ed o ha e some bene icial e ec s in animal models o Pa kinson’s disease (Van Kampen e al., 2014). Howe e , due o hei chemical p ope ies, i is unclea how easily he ginsenosides c oss he in ac blood- b ain ba ie . A ecen s udy sugges s ginsenosides can be de ec ed in a ascula endo helial cells and as ocy es ollowing o al adminis a ion o high pu i y ginseng o al saponins (Zhao e al., 2018). The la ge ginsenosides wi h mul iple suga moie ies a e much less likely o be abso bed om he in es ine in o he bloods eam, bu he smalle ginsenosides and me aboli es such as CK a e ound a app eciable concen a ions in plasma and li e . Peak plasma concen a ions o CK a e epo ed o be 8.35 ng/ml (low nM ange) in humans ollowing o al adminis a ion o Ko ean ed ginseng ex ac (Kim, 2013), al hough a mo e ecen s udy ound highe plasma concen a ions (1183.2 6445.1 ng/ml ollowing a single 800 mg dose) in olun ee s ecei ing pu e Ginsenoside CK able s (Chen e al., 2018). Fu he mo e, he sou ce o he ginsenosides, whe he om a na u al ex ac , Fig. 7. Ginsenosides show li le po en ia ion o ATP-induced esponses in BV-2 mic oglia in he absence o P2X7. (A and B) In acellula calcium measu emen s we e pe o med using a no-wash Fu a-2-QBT assay on pa en al BV-2 cells and P2X7-de icien BV-2 mic oglia cells. ATP (200 mM) was injec ed in he absence o p esence o a ious ginsenosides (all 10 mM). Calcium esponses we e calcula ed as a ea unde cu e using So max P o so wa e. Signi ican po en ia ion was only e iden in cells exp essing P2X7. Da a a e om h ee independen expe imen s, e o ba s ep esen S.D., and *indica es P,0.05 using wo-way ANOVA wi h Bon e oni’s mul iple compa ison pos hoc es . (C) Cell iabili y was assessed using MTS eagen .BV-2cellswe epla ed o 24hou sp io os imula ionwi hATPin heabsenceo p esenceo ginsenosideCK(10mM). Cells we e ea ed o 24 hou s, and MTS was added o he inal 1 hou . Da a a e ep esen ed as mean pe cen age o con ol alues in which con ol was ehicle- ea ed cells. Da a a e om h ee independen expe imen s, e o ba s ep esen S.D., and *indica es P,0.05 using one-way ANOVA wi h Dunne ’s mul iple compa ison pos hoc es . 218 Dhuna e al. a ASPET Jou nals on June 8, 2020molpha m.aspe jou nals.o gDownloaded om